![David John Gregory Jennings](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David John Gregory Jennings
Financieel Directeur/CFO bij Cerus Endovascular Ltd.
Profiel
David John Gregory Jennings is currently working as Secretary, Chief Financial Officer & Director at Cerus Endovascular Ltd.
and as Director at Cerus Endovascular, Inc. He has previously worked as Chief Financial Officer at Tissue Science Laboratories Ltd., Chief Financial Officer at DYSIS Medical Ltd., and Head-Finance at RSM Tenon Group Plc.
Actieve functies van David John Gregory Jennings
Bedrijven | Functie | Begin |
---|---|---|
Cerus Endovascular, Inc.
![]() Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Directeur/Bestuurslid | - |
Cerus Endovascular Ltd.
![]() Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Financieel Directeur/CFO | - |
Eerdere bekende functies van David John Gregory Jennings
Bedrijven | Functie | Einde |
---|---|---|
DYSIS Medical Ltd.
![]() DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Financieel Directeur/CFO | - |
RSM TENON GROUP PLC | Financieel Directeur/CFO | - |
Tissue Science Laboratories Ltd.
![]() Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Tissue Science Laboratories Ltd.
![]() Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom. | Health Technology |
DYSIS Medical Ltd.
![]() DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Health Technology |
RSM Tenon Group Plc
![]() RSM Tenon Group Plc Miscellaneous Commercial ServicesCommercial Services RSM Tenon Group Plc provided entrepreneurial professional services. It offered audit and accounts, business finance, consultancy, corporate finance, corporate recovery, financial management, forensic accounting, information systems assurance, internal audit, outsourcing, risk management and software solutions. The company was founded in February 2000 and was headquartered in London, the United Kingdom. | Commercial Services |
Cerus Endovascular, Inc.
![]() Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Health Technology |
Cerus Endovascular Ltd.
![]() Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Health Technology |